Effects of virtual reality in phase I cardiac rehabilitation training for elderly coronary heart disease patients after percutaneous coronary intervention.
- Author:
Ying WANG
1
;
Sheng-Lan YANG
1
;
Su-Xin LUO
1
;
Hua TONG
1
;
Qin FANG
2
;
Yong-Zheng GUO
3
Author Information
1. Division of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
2. Division of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. 949560838@hospital.cqmu.edu.cn.
3. Division of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. gyz_cardio@hospital.cqmu.edu.cn.
- Publication Type:Randomized Controlled Trial
- MeSH:
Aged;
Humans;
Anxiety;
Cardiac Rehabilitation/methods*;
Coronary Disease/surgery*;
Percutaneous Coronary Intervention/adverse effects*;
Virtual Reality
- From:
Acta Physiologica Sinica
2023;75(6):953-961
- CountryChina
- Language:Chinese
-
Abstract:
The study aimed to examine the effects of virtual reality (VR) technology-based phase I cardiac rehabilitation (CR) program in elderly coronary heart disease (CHD) patients after percutaneous coronary intervention (PCI). Thirty-six cases of elderly CHD patients who underwent PCI in the First Affiliated Hospital of Chongqing Medical University from June 2022 to April 2023 were recruited by convenience sampling method. The patients were randomly assigned by means of random digital table method to two study groups: control group (n = 18), which received conventional nursing intervention after PCI, and experimental group (n = 18), which received a combined program of conventional nursing intervention together with CR program based on VR technology. The 6 min walk test (6MWT), Simple Physical Performance Battery (SPPB), SF-36 scale, Hospital Anxiety and Depression Scale (HADS) and Impact of Events Scale-Revised (IES-R) were tested before and after rehabilitation. Moreover, the incidence of major adverse cardiovascular events (MACE) was recorded at 3 months after PCI. After VR-based CR, the 6MWT distance and SPPB scores of patients in the experimental group were higher than those in control group (P < 0.05). The HADS scores and IES-R scores of the patients in the experimental group were lower than those in control group (P < 0.01), and the difference in SF-36 scale scores was not statistically significant between two groups (P > 0.05). The incidence of MACE was not significantly different at 3 months after PCI (P > 0.05). These results suggest that VR-based phase I CR program mitigates the degree of PCI postoperative stress, anxiety, and depression in elderly CHD patients, however, enhances the resistance to fatigue and does not increase the risk of adverse cardiac events, suggesting it is a safe intervention.
